Zimmer Biomet Holdings, Inc. (SWX:ZBH)
109.00
0.00 (0.00%)
At close: Jul 18, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Knees Net Sales | 3.17B | Log In | Log In | Log In | Log In | Upgrade |
Knees Net Sales Growth | 3.73% | Log In | Log In | Log In | Log In | Upgrade |
Hips Net Sales | 2.00B | Log In | Log In | Log In | Log In | Upgrade |
Hips Net Sales Growth | 1.94% | Log In | Log In | Log In | Log In | Upgrade |
S.E.T. Net Sales | 1.87B | Log In | Log In | Log In | Log In | Upgrade |
S.E.T. Net Sales Growth | 6.31% | Log In | Log In | Log In | Log In | Upgrade |
Other Net Sales | 640.30M | Log In | Log In | Log In | Log In | Upgrade |
Other Net Sales Growth | -2.80% | Log In | Log In | Log In | Log In | Upgrade |
Spine & Dental Net Sales | - | Log In | Log In | Log In | Log In | Upgrade |
Spine & Dental Net Sales Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
EMEA Operating Profit | Log In | Log In | Log In | Log In | Upgrade |
EMEA Operating Profit Growth | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Operating Profit | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Operating Profit Growth | Log In | Log In | Log In | Log In | Upgrade |
Americas Orthopedics Operating Profit | Log In | Log In | Log In | Log In | Upgrade |
Americas Orthopedics Operating Profit Growth | Log In | Log In | Log In | Log In | Upgrade |
Americas Spine & Global Dental Operating Profit | Log In | Log In | Log In | Log In | Upgrade |
Americas Spine & Global Dental Operating Profit Growth | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Americas Segment Profit | 2.58B | Log In | Log In | Log In | Log In | Upgrade |
Americas Segment Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EMEA Segment Profit | 585.80M | Log In | Log In | Log In | Log In | Upgrade |
EMEA Segment Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Segment Profit | 457.60M | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Segment Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
EMEA Net Sales | 1.69B | Log In | Log In | Log In | Log In | Upgrade |
EMEA Net Sales Growth | 4.83% | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Net Sales | 1.19B | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Net Sales Growth | 2.13% | Log In | Log In | Log In | Log In | Upgrade |
Americas Orthopedics Net Sales | 4.79B | Log In | Log In | Log In | Log In | Upgrade |
Americas Orthopedics Net Sales Growth | 3.07% | Log In | Log In | Log In | Log In | Upgrade |
Americas Spine & Global Dental Net Sales | - | Log In | Log In | Log In | Log In | Upgrade |
Americas Spine & Global Dental Net Sales Growth | - | Log In | Log In | Log In | Log In | Upgrade |